Health Care & Life Sciences » Pharmaceuticals | PharmaRoth Labs Inc.

PharmaRoth Labs Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
0.60
5.80
0.80
0.80
1.20
Total Accounts Receivable
94.60
172.40
78.10
30.00
82.70
Inventories
14.50
35.20
45.20
101.70
150.50
Other Current Assets
50.40
77.70
84.70
74.30
69.80
Total Current Assets
160.00
291.10
208.80
206.70
304.10
Net Property, Plant & Equipment
0.70
-
-
-
-
Total Assets
160.70
291.10
208.80
206.70
304.10
ST Debt & Current Portion LT Debt
-
-
-
250.00
250.00
Accounts Payable
91.00
40.00
52.20
37.80
118.20
Income Tax Payable
48.80
69.00
-
-
-
Other Current Liabilities
454.80
541.30
625.30
411.70
495.10
Total Current Liabilities
594.60
650.30
677.50
699.50
863.30
Total Liabilities
594.60
650.30
677.50
699.50
863.30
Common Equity (Total)
431.20
358.00
458.80
482.80
549.50
Total Shareholders' Equity
431.20
358.00
458.80
482.80
549.50
Total Equity
433.90
359.20
468.80
492.80
559.30
Liabilities & Shareholders' Equity
160.70
291.10
208.80
206.70
304.10
Accumulated Minority Interest
2.70
1.10
10.00
10.00
9.80

About PharmaRoth Labs

View Profile
Address
10080 West Alta Drive
Las Vegas Nevada 89145
United States
Employees -
Website http://www.pharmaroth.com
Updated 07/08/2019
PharmaRoth Labs, Inc. focuses on diabetes prevention and treatments. It holds the intellectual property rights related to the production, marketing and distribution of Sucanon, a oral treatment for type II diabetes. The company was founded on December 11, 2000 and is headquartered in Las Vegas, NV.